Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kehuang is a Traditional Chinese Medicine (TCM) herbal formulation developed as a hospital preparation by the Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine. It is specifically indicated for the treatment of rosacea. The formulation is a combination of several botanical extracts, typically including *Sophora flavescens* (Kushen), *Rheum palmatum* (Dahuang), *Scutellaria baicalensis* (Huangqin), and *Phellodendron amurense* (Huangbai). These ingredients are traditionally recognized for their ability to clear heat and detoxify. Modern pharmacological research suggests that Kehuang exerts its therapeutic effects through anti-inflammatory, antimicrobial, and immunomodulatory mechanisms, specifically by inhibiting pro-inflammatory cytokines and modulating the skin's immune response to alleviate erythema, papules, and pustules associated with rosacea.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on kehuang.